Global Beta-Nicotinamide Mononucleotide (NMN) Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Beta-Nicotinamide Mononucleotide (NMN) Market Overview

1.1 Beta-Nicotinamide Mononucleotide (NMN) Definition

1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Status and Outlook (2019-2032)

1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Comparison by Region (2019-2032)

1.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Comparison by Type (2019-2032)

1.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Comparison by Application (2019-2032)

1.6 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Comparison by Sales Channel (2019-2032)

1.7 Beta-Nicotinamide Mononucleotide (NMN) Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Snapshot

2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Volume & Revenue (2019-2025)

2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Beta-Nicotinamide Mononucleotide (NMN) Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Beta-Nicotinamide Mononucleotide (NMN) Market Segment Analysis by Player

3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Player (2023-2025)

3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Player (2023-2025)

3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Beta-Nicotinamide Mononucleotide (NMN) Market Segment Analysis by Type

4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market by Type

4.1.1 Content 98% & above

4.1.2 Content below 98%

4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Type (2019-2025)

4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2019-2025)

4.4 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2025)

4.5 Leading Players of Beta-Nicotinamide Mononucleotide (NMN) by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Beta-Nicotinamide Mononucleotide (NMN) Market Segment Analysis by Application

5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market by Application

5.1.1 Health Care Products

5.1.2 Cosmetics

5.1.3 Others

5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Beta-Nicotinamide Mononucleotide (NMN) by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Beta-Nicotinamide Mononucleotide (NMN) Market Segment Analysis by Sales Channel

6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market by Sales Channel

6.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Beta-Nicotinamide Mononucleotide (NMN) by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Beta-Nicotinamide Mononucleotide (NMN) Market Segment Analysis by Region

7.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size and CAGR by Region (2019-2032)

7.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales and Market Share by Region (2019-2025)

7.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Beta-Nicotinamide Mononucleotide (NMN) Market Share by Type

7.4.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Share by Type

7.5.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Share by Type

7.6.3 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Beta-Nicotinamide Mononucleotide (NMN) Market Share by Type

7.7.3 South America Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Market Share by Type

7.8.3 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Beta-Nicotinamide Mononucleotide (NMN) Players

8.1 GeneHarbor

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Herbalmax

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Genex Formulas

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Shinkowa Pharmaceutical

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Maac10 Formulas

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 EffePharm

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Bontac

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 CELFULL

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Kingdomway

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Beta-Nicotinamide Mononucleotide (NMN)

9.1 Industrial Chain of Beta-Nicotinamide Mononucleotide (NMN)

9.2 Upstream of Beta-Nicotinamide Mononucleotide (NMN)

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Beta-Nicotinamide Mononucleotide (NMN)

9.3.1 Leading Distributors/Dealers of Beta-Nicotinamide Mononucleotide (NMN)

9.3.2 Leading Consumers of Beta-Nicotinamide Mononucleotide (NMN)

Chapter 10. Global Beta-Nicotinamide Mononucleotide (NMN) Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Beta-Nicotinamide Mononucleotide (NMN) Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Beta-Nicotinamide Mononucleotide (NMN) Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Beta-Nicotinamide Mononucleotide (NMN) (2026-2032)

11.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Beta-Nicotinamide Mononucleotide (NMN) Import-Export (2019-2025)

12.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Import-Export (2019-2025)

12.3 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Import-Export (2019-2025)

12.4 South America Beta-Nicotinamide Mononucleotide (NMN) Import-Export (2019-2025)

12.5 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Beta-Nicotinamide Mononucleotide (NMN) Demand-Supply (2019-2025)

13.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Demand-Supply (2019-2025)

13.3 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Demand-Supply (2019-2025)

13.4 South America Beta-Nicotinamide Mononucleotide (NMN) Demand-Supply (2019-2025)

13.5 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources